Other
91 - 105 of
123 Results
Sort Results:
Article:
a possible increase in acute pancreatitis risk with gliptins (Januvia, etc) and GLP-1 agonists (Byetta, etc)
April 2013
Article:
three more pancrelipase products, Ultresa (ul-TRES-a), Viokace (VYE-oh-kase), and Pertzye (PERT-zye)
January 2013